-->
/ / / FDA panel recommends pulling Makena, citing ineffectiveness of controversial preterm birth drug

FDA panel recommends pulling Makena, citing ineffectiveness of controversial preterm birth drug

The FDA advisory panel, made up of gynecologists, obstetricians and other fetal medicine experts, voted 14-1 to withdraw Makena from the market.

     


from USATODAY - News Top Stories https://ift.tt/CeYzNAs
via

Related Posts with FDA panel recommends pulling Makena, citing ineffectiveness of controversial preterm birth drug